Health
Study: Thymoquinone selectively kills prostate cancer cells at advanced stages – News-Medical.Net
The compound thymoquinone (TQ) selectively kills prostate cancer cells at advanced stages, according to a new study published in Oncogene.
Reviewed by Emily Henderson, B.Sc.Oct 8 2020
The compound thymoquinone (TQ) selectively kills prostate cancer cells at advanced stages, according to a new study published in Oncogene. Led by researchers at Kanazawa University, the study reports that prostate cancer cells with a deletion of the SUCLA2 gene can be therapeutically targeted.
SUCLA2-deficient prostate cancers represent a significant fraction of those resistant to hormone therapy or metastatic, and a new therapeutic option for this …
-
Noosa News13 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
Noosa News23 hours agoMan shot in the leg during attempted break-in at Beenleigh, Queensland
-
General14 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Business19 hours agoDown 20% this year, here are 3 reasons why I’m still loading up on Amazon stock